Evidence map›Paper›PMID 38545088›Full record

ReviewEClinicalMedicine2024

Disproportionate infection, hospitalisation and death from COVID-19 in ethnic minority groups and Indigenous Peoples: an application of the Priority Public Health Conditions analytical framework.

Patricia Irizar, Daniel Pan, Harry Taylor, Christopher A Martin, Srinivasa Vittal Katikireddi, Niluka Wijekoon Kannangarage, Susana Gomez, Daniel La Parra Casado, Prashanth Nuggehalli Srinivas, Finn Diderichsen and 4 more

Open access · goldAbstract readReview
In one paragraph

Review in EClinicalMedicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 5 countries.

Patricia IrizarFaculty of Humanities, School of Social Sciences, University of Manchester, UK.
Daniel PanDepartment of Respiratory Sciences, University of Leicester, UK.
Harry TaylorDepartment of Global Health and Social Medicine, King's College London, UK.
Christopher A MartinDepartment of Respiratory Sciences, University of Leicester, UK.
Srinivasa Vittal KatikireddiMRC/CSO Social and Public Health Sciences Unit, University of Glasgow, UK.
Niluka Wijekoon KannangarageWorld Health Organization, Geneva, Switzerland.
Susana GomezWorld Health Organization, Geneva, Switzerland.
Daniel La Parra CasadoDepartment of Sociology, University of Alicante, Spain.
Prashanth Nuggehalli SrinivasInstitute of Public Health, Bengaluru, India.
Finn DiderichsenUniversity of Copenhagen, Copenhagen, Denmark.
Rebecca F BaggaleyLeicester NIHR Biomedical Research Centre, UK.
Laura B NellumsLifespan and Population Sciences, School of Medicine, University of Nottingham, UK.
Theadora Swift KollerWorld Health Organization, Geneva, Switzerland.
Manish PareekDepartment of Respiratory Sciences, University of Leicester, UK.
University of Leicester · GBWorld Health Organization · CHInstitute of Public Health Bengaluru · INKing's College London · GBMRC/CSO Social and Public Health Sciences Unit · GBUniversity of Alicante · ESUniversity of Copenhagen · DKUniversity of Manchester · GBUniversity of Nottingham · GB

Funding

DBT-Wellcome Trust India Alliance IA/CRC/20/1/600007Wellcome TrustWorld Health Organization 001
6 · The paper itself

Abstract

The COVID-19 pandemic has resulted in disproportionate consequences for ethnic minority groups and Indigenous Peoples. We present an application of the Priority Public Health Conditions (PPHC) framework from the World Health Organisation (WHO), to explicitly address COVID-19 and other respiratory viruses of pandemic potential. This application is supported by evidence that ethnic minority groups were more likely to be infected, implying differential exposure (PPHC level two), be more vulnerable to severe disease once infected (PPHC level three) and have poorer health outcomes following infection (PPHC level four). These inequities are driven by various interconnected dimensions of racism, that compounds with socioeconomic context and position (PPHC level one). We show that, for respiratory viruses, it is important to stratify levels of the PPHC framework by infection status and by societal, community, and individual factors to develop optimal interventions to reduce inequity from COVID-19 and future infectious diseases outbreaks.

Indexed as

COVID-19EthnicityHealth inequityIndigenousRaceSARS-CoV-2

Identifiers

PMID38545088
PMCPMC10965404
OpenAlexW4390675793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.